Status:

COMPLETED

MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.

Lead Sponsor:

Sheba Medical Center

Conditions:

Iron Overload

Eligibility:

All Genders

18-35 years

Brief Summary

Sickle cell anemia and Sickle cell β thalassemia patients require multiple transfusions in order to avoid chronic anemia sequel. This regimen entails intrinsic deleterious effects, the majority of whi...

Detailed Description

Sickle cell anemia and Sickle cell β thalassemia patients recieving multiple transfusions are exposed to the effects of iron deposition in the reticuloendothelial system, including cardiac muscle, liv...

Eligibility Criteria

Inclusion

  • clinical diagnosis of Sickle cell anemia or Sickle cell β thalassemia having received multiple blood transfusions.

Exclusion

  • contraindication to MRI

Key Trial Info

Start Date :

January 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2010

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00629291

Start Date

January 1 2008

End Date

May 1 2010

Last Update

May 11 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sheba Medical Center , Imaging Dept

Tel Litwinsky, Tel Hashomer, Israel, 52621

MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions. | DecenTrialz